How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

267,329 results for

Risk Management

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

61. Hypertension in adults: diagnosis and management

] 1.2.12 Consider the need for specialist investigations in people with signs and symptoms suggesting a secondary cause of hypertension. [2004, amended [2004, amended 2011] 2011] T o find out why the committee made the 2019 recommendations on diagnosing hypertension and how they might affect practice, see rationale and impact. 1.3 Assessing cardiovascular risk and target organ damage For guidance on the early identification and management of chronic kidney disease, see NICE's guideline on chronic (...) Hypertension in adults: diagnosis and management Hypertension in adults: diagnosis and Hypertension in adults: diagnosis and management management NICE guideline Published: 28 August 2019 www.nice.org.uk/guidance/ng136 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful consideration

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

62. Thyroid disease: assessment and management

Thyroid disease: assessment and management Thyroid disease: assessment and management NICE guideline Published: 20 November 2019 www.nice.org.uk/guidance/ng145 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement (...) may feel well even when their thyroid function tests are outside the reference range. Even when there are no symptoms, treatment may be advised to reduce the risk of long-term complications. Even when thyroid function tests are within the reference range, changes to treatment may improve symptoms for some people. Symptoms may lag behind treatment changes for several weeks to months. Thyroid disease: assessment and management (NG145) © NICE 2019. All rights reserved. Subject to Notice of rights

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

63. Diverticular disease: diagnosis and management

Diverticular disease: diagnosis and management Diverticular disease: diagnosis and management NICE guideline Published: 27 November 2019 www.nice.org.uk/guidance/ng147 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising (...) disease and how they might affect practice, see rationale and impact. Management and advice Management and advice 1.2.4 Do not offer antibiotics to people with diverticular disease. 1.2.5 Advise people to avoid non-steroidal anti-inflammatory drugs and opioid analgesia if possible, because they may increase the risk of diverticular perforation. 1.2.6 For advice on diet, fluid intake, stopping smoking, weight loss and exercise, follow the recommendations in section 1.1 on diverticulosis. 1.2.7 Advise

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

64. Prostate cancer: diagnosis and management

Prostate cancer: diagnosis and management Prostate cancer: diagnosis and Prostate cancer: diagnosis and management management NICE guideline Published: 9 May 2019 www.nice.org.uk/guidance/ng131 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When (...) pathological stage predict risk of treatment failure. [2008] [2008] 1.1.8 Explain the reliability, validity and limitations of any predictions made using nomograms. [2008] [2008] 1.1.9 Discuss all relevant management options in this guideline with people with prostate cancer and their partners or carers, even if they are not available through their local services. [2008] [2008] 1.1.10 T ell people with prostate cancer: about treatment options and their risks and benefits in an objective, unbiased manner

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

65. Depression in children and young people: identification and management

this when we update the 2005 recommendations. The guidance follows these 5 steps: 1. Detection and recognition of depression and risk profiling in primary care and community settings. 2. Recognition of depression in children and young people referred to Children and Young People's Mental Health Services (including CAMHS). 3. Managing recognised depression in primary care and community settings – mild depression. 4. Managing recognised depression in tier 2 or 3 [1] CAMHS – moderate to severe depression (...) Depression in children and young people: identification and management Depression in children and y Depression in children and young people: oung people: identification and management identification and management NICE guideline Published: 25 June 2019 www.nice.org.uk/guidance/ng134 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

66. Hypertension in pregnancy: diagnosis and management

Hypertension in pregnancy: diagnosis and management Hypertension in pregnancy: diagnosis Hypertension in pregnancy: diagnosis and management and management NICE guideline Published: 25 June 2019 www.nice.org.uk/guidance/ng133 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful consideration (...) is it for? 5 Recommendations 6 1.1 Reducing the risk of hypertensive disorders in pregnancy 6 1.2 Assessment of proteinuria in hypertensive disorders of pregnancy 8 1.3 Management of chronic hypertension in pregnancy 9 1.4 Management of gestational hypertension 13 1.5 Management of pre-eclampsia 17 1.6 Fetal monitoring 24 1.7 Intrapartum care 26 1.8 Medical management of severe hypertension, severe pre-eclampsia or eclampsia in a critical care setting 27 1.9 Antihypertensive treatment during the postnatal

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

67. Hyperparathyroidism (primary): diagnosis, assessment and initial management

Hyperparathyroidism (primary): diagnosis, assessment and initial management Hyperpar Hyperparath athyroidism (primary): yroidism (primary): diagnosis, assessment and initial diagnosis, assessment and initial management management NICE guideline Published: 23 May 2019 www.nice.org.uk/guidance/ng132 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations (...) 1.1.1 Measure albumin-adjusted serum calcium for people with any of the following features, which might indicate primary hyperparathyroidism: symptoms of hypercalcaemia, such as thirst, frequent or excessive urination, or constipation osteoporosis or a previous fragility fracture (for recommendations on assessing the risk of fragility fracture in people with osteoporosis, see the NICE guideline on osteoporosis) a renal stone (for recommendations on assessing and managing renal stones, see the NICE

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

68. Crohn’s disease: management

Crohn’s disease: management Crohn Crohn’s disease: management ’s disease: management NICE guideline Published: 3 May 2019 www.nice.org.uk/guidance/ng129 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement (...) or carers (as appropriate). [2012] [2012] 1.1.4 Give all people with Crohn's disease and their family members or carers (as appropriate) information, advice and support in line with published NICE guidance on: smoking cessation patient experience medicines adherence fertility. [2012] [2012] Crohn’s disease: management (NG129) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 5 of 221.1.5 Give people with Crohn's disease

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

69. Ulcerative colitis: management

Ulcerative colitis: management Ulcer Ulcerativ ative colitis: management e colitis: management NICE guideline Published: 3 May 2019 www.nice.org.uk/guidance/ng130 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement (...) of disease 1.2.14 For guidance on biologics and Janus kinase inhibitors for treating moderately to severely active ulcerative colitis, see the NICE technology appraisal guidance on: infliximab, adalimumab and golimumab for moderately to severely active ulcerative colitis vedolizumab for treating moderately to severely active ulcerative colitis Ulcerative colitis: management (NG130) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

70. Stroke and transient ischaemic attack in over 16s: diagnosis and initial management

Stroke and transient ischaemic attack in over 16s: diagnosis and initial management Strok Stroke and tr e and transient ischaemic attack in ansient ischaemic attack in o ov ver 16s: diagnosis and initial er 16s: diagnosis and initial management management NICE guideline Published: 1 May 2019 www.nice.org.uk/guidance/ng128 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility (...) assessment and investigation, to be seen within 24 hours of onset of symptoms. [2019] [2019] 1.1.6 Do not use scoring systems, such as ABCD2, to assess risk of subsequent stroke or to inform urgency of referral for people who have had a suspected or confirmed TIA. [2019] [2019] Stroke and transient ischaemic attack in over 16s: diagnosis and initial management (NG128) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 5

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

71. Renal and ureteric stones: assessment and management

Renal and ureteric stones: assessment and management Renal and ureteric stones: assessment Renal and ureteric stones: assessment and management and management NICE guideline Published: 8 January 2019 nice.org.uk/guidance/ng118 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful (...) waiting after an informed discussion of the possible risks and benefits. Renal and ureteric stones: assessment and management (NG118) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 7 of 331.5.2 Follow the recommendations in table 1 for surgical treatment (including SWL) of renal stones in adults, children and young people. T T able able 1 Surgical treatment (including SWL) of renal stones in adults, children and 1

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

72. Fever in under 5s: assessment and initial management

is largely an interpretation of symptoms rather than physical signs. The guidance in this section may also apply to healthcare professionals whose scope of practice does not include the physical examination of a young child (for example, community pharmacists). Management according to risk of serious illness Management according to risk of serious illness 1.3.1 Healthcare professionals performing a remote assessment of a child with fever should seek to identify symptoms and signs of serious illness (...) Fever in under 5s: assessment and initial management Fever in under 5s: assessment and initial management NICE guideline Published: 7 November 2019 www.nice.org.uk/guidance/ng143 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

73. Ectopic pregnancy and miscarriage: diagnosis and initial management

Ectopic pregnancy and miscarriage: diagnosis and initial management Ectopic pregnancy and miscarriage: Ectopic pregnancy and miscarriage: diagnosis and initial management diagnosis and initial management NICE guideline Published: 17 April 2019 nice.org.uk/guidance/ng126 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view (...) ' gestation or more or or a pregnancy of uncertain gestation. The urgency of this referral depends on the clinical situation. [2012] [2012] 1.3.10 Use expectant management for women with a pregnancy of less than 6 weeks' gestation who are bleeding but not in pain, and who have no risk factors, such as a previous ectopic pregnancy. Advise these women: to return if bleeding continues or pain develops Ectopic pregnancy and miscarriage: diagnosis and initial management (NG126) © NICE 2019. All rights reserved

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

74. Urinary incontinence and pelvic organ prolapse in women: management

Urinary incontinence and pelvic organ prolapse in women: management Urinary incontinence and pelvic organ Urinary incontinence and pelvic organ prolapse in women: management prolapse in women: management NICE guideline Published: 2 April 2019 nice.org.uk/guidance/ng123 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view (...) catheterisation. Discuss the practicalities, benefits and risks with the woman or, if appropriate, her carer. Indications for the use of long-term indwelling urethral catheters for women with urinary incontinence include: chronic urinary retention in women who are unable to manage intermittent self- catheterisation skin wounds, pressure ulcers or irritations that are being contaminated by urine distress or disruption caused by bed and clothing changes where a woman expresses a preference for this form

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

75. Nudging people with Type 2 diabetes towards better self-management through personalized risk communication: A pilot randomized controlled trial in primary care. Full Text available with Trip Pro

Nudging people with Type 2 diabetes towards better self-management through personalized risk communication: A pilot randomized controlled trial in primary care. To assess the feasibility in routine primary care consultation and investigate the effect on risk recall and self-management of a new type of risk communication intervention based on behavioural economics ("nudge-based") for people with Type 2 diabetes mellitus (T2DM).Forty adults with poorly controlled T2DM (HbA1c > 7.5%) were (...) randomized to receive a personalized, nudge-based risk communication intervention (n = 20) or standard care (n = 20). Risk recall and self-management were evaluated at baseline and 12 weeks after the intervention.Both in terms of feasibility and acceptability, this new risk communication intervention was very satisfactory. Study retention rate after 12 weeks was very high (90%) and participants were highly satisfied with the intervention (4.4 out of 5 on the COMRADE scale). Although not powered

2018 Endocrinology, diabetes & metabolism Controlled trial quality: uncertain

76. Efficacy of a proactive health and safety risk management system in the fire service Full Text available with Trip Pro

Efficacy of a proactive health and safety risk management system in the fire service This study evaluated the efficacy of a fire department proactive risk management program aimed at reducing firefighter injuries and their associated costs.Injury data were collected for the intervention fire department and a contemporary control department. Workers' compensation claim frequency and costs were analyzed for the intervention fire department only. Total, exercise, patient transport, and fireground (...) operations injury rates were calculated for both fire departments.There was a post-intervention average annual reduction in injuries (13%), workers' compensation injury claims (30%) and claims costs (21%). Median monthly injury rates comparing the post-intervention to the pre-intervention period did not show statistically significant changes in either the intervention or control fire department.Reduced workers' compensation claims and costs were observed following the risk management intervention

2018 Injury epidemiology

77. The impact of social capital on clinical risk management in nursing: a survey in Iranian public educational hospitals Full Text available with Trip Pro

The impact of social capital on clinical risk management in nursing: a survey in Iranian public educational hospitals This study aimed to explore the social capital impact on clinical risk management from nurses' viewpoints.This was a cross-sectional and analytical study conduct in six public educational hospitals affiliated to Tehran University of Medical Sciences (TUMS).Questionnaires were used as the data collection tool. Data were analysed using descriptive statistics, parametric and non (...) -parametric tests by SPSS 16 at a significance level of 0.05.Risk management, social capital and all its three dimensions evaluated in moderate level. It is confirmed that the social capital is one of the factors associated with the improvement of clinical risk management. There was a significant relationship between clinical risk management and social capital. In this respect, hospital managers and decision-makers could enhance clinical risk management by identifying and increasing different dimensions

2018 Nursing open

78. Review on the prevalence, risk factors and disease Management of Hypertension among floating population in China during 1990–2016 Full Text available with Trip Pro

Review on the prevalence, risk factors and disease Management of Hypertension among floating population in China during 1990–2016 To have a basic and comprehensive understanding about the prevalence, risk factors and disease management situation of hypertension among floating population in China.We used "(hypertension or hypertensive or chronic disease) and (floating population or migrant worker)" as the key words, to search in the China academic literature database (CNKI), Wan Fang database (...) , PubMed and Web of Science for relevant literature and extracted the data about the prevalence of hypertension, relevant risk factors and disease management of floating population in China from 1990 to 2016.The 23 related studies that entered into final analysis were all articles in Chinese. The prevalence of hypertension in floating population is lower than that in both general population and local residents. The prevalence of hypertension in male floating population is higher than that in females

2018 Global health research and policy

79. Risk Factor Management in Atrial Fibrillation Full Text available with Trip Pro

Risk Factor Management in Atrial Fibrillation Atrial fibrillation (AF) is the most common clinical arrhythmia and is associated with increased morbidity and mortality. There is growing evidence that numerous cardiovascular diseases and risk factors are associated with incident AF and that lone AF is rare. Beyond oral anticoagulant therapy, rate and rhythm control, therapy targeting risk factors and underlying conditions is an emerging AF management strategy that warrants better implementation (...) in clinical practice. This review describes current evidence regarding the association between known modifiable risk factors and underlying conditions and the development and progression of AF. It discusses evidence for the early management of underlying conditions to improve AF outcomes. It also provides perspective on the implementation of tailored AF management in daily clinical practice.

2018 Arrhythmia & electrophysiology review

80. Task-shifting for cardiovascular risk factor management: lessons from the Global Alliance for Chronic Diseases Full Text available with Trip Pro

Task-shifting for cardiovascular risk factor management: lessons from the Global Alliance for Chronic Diseases Task-shifting to non-physician health workers (NPHWs) has been an effective model for managing infectious diseases and improving maternal and child health. There is inadequate evidence to show the effectiveness of NPHWs to manage cardiovascular diseases (CVDs). In 2012, the Global Alliance for Chronic Diseases funded eight studies which focused on task-shifting to NPHWs (...) for the management of hypertension. We report the lessons learnt from the field. From each of the studies, we obtained information on the types of tasks shifted, the professional level from which the task was shifted, the training provided and the challenges faced. Additionally, we collected more granular data on 'lessons learnt ' throughout the implementation process and 'design to implementation' changes that emerged in each project. The tasks shifted to NPHWs included screening of individuals, referral

2018 BMJ global health

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>